YI 111, Inc.
Healthcare$5.33-6.49%ClosedMarket Cap: $46.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.48
P/S
0.03
EV/EBITDA
-2.07
DCF Value
$-41.78
FCF Yield
-3.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
5.8%
Operating Margin
-0.1%
Net Margin
-0.4%
ROE
8.3%
ROA
-2.5%
ROIC
-1.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $2.78B | 5.8% | $-4.6M | $-5.9M | $— | — |
| FY null | $12.21B | 5.8% | $-10.0M | $-16.8M | $— | — |
| Q3 null | $3.00B | 5.9% | $-2.3M | $-13.0M | $— | — |
| Q2 null | $3.21B | 5.8% | $95.0K | $-19.5M | $— | — |
| Q1 null | $3.53B | 5.5% | $145.0K | $-17.6M | $— | — |
| Q4 null | $3.85B | 5.3% | $-7.3M | $-19.8M | $— | — |
| FY null | $14.40B | 5.8% | $2.1M | $-64.7M | $— | — |
| Q3 null | $3.60B | 5.8% | $2.4M | $-17.1M | $— | — |
| Q2 null | $3.42B | 6.1% | $3.3M | $-14.0M | $— | — |
| Q1 null | $3.53B | 5.9% | $3.7M | $-13.8M | $— | — |
| Q4 2023 | $4.11B | -4.5% | $-206.5M | $-210.4M | $-24.76 | — |
| FY null | $14.95B | 5.7% | $-350.1M | $-392.7M | $— | — |